231 related articles for article (PubMed ID: 21765362)
1. Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: a survey conducted among adolescents in Soweto, South Africa.
Otwombe KN; Sikkema KJ; Dietrich J; de Bruyn G; van der Watt M; Gray GE
J Acquir Immune Defic Syndr; 2011 Oct; 58(2):211-8. PubMed ID: 21765362
[TBL] [Abstract][Full Text] [Related]
2. Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.
O'Connell JM; Hogg RS; Chan K; Strathdee SA; McLean N; Martindale SL; Willoughby B; Remis R
J Acquir Immune Defic Syndr; 2002 Dec; 31(5):521-8. PubMed ID: 12473841
[TBL] [Abstract][Full Text] [Related]
3. Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.
Moodie Z; Metch B; Bekker LG; Churchyard G; Nchabeleng M; Mlisana K; Laher F; Roux S; Mngadi K; Innes C; Mathebula M; Allen M; Bentley C; Gilbert PB; Robertson M; Kublin J; Corey L; Gray GE
PLoS One; 2015; 10(9):e0137666. PubMed ID: 26368824
[TBL] [Abstract][Full Text] [Related]
4. Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents.
Giocos G; Kagee A; Swartz L
AIDS Behav; 2008 Nov; 12(6):842-51. PubMed ID: 17668313
[TBL] [Abstract][Full Text] [Related]
5. Willingness to participate in HIV therapeutic vaccine trials among HIV-infected patients on ART in China.
Dong Y; Shen X; Guo R; Liu B; Zhu L; Wang J; Zhang L; Sun J; Zhang X; Xu J
PLoS One; 2014; 9(11):e111321. PubMed ID: 25372044
[TBL] [Abstract][Full Text] [Related]
6. Adolescent and adult participation in an HIV vaccine trial preparedness cohort in South Africa.
Middelkoop K; Myer L; Mark D; Mthimunye SP; Smit J; Wood R; Bekker LG
J Adolesc Health; 2008 Jul; 43(1):8-14. PubMed ID: 18565432
[TBL] [Abstract][Full Text] [Related]
7. Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study.
Mayanja Y; Abaasa A; Namale G; Price MA; Kamali A
BMC Public Health; 2020 Nov; 20(1):1789. PubMed ID: 33239018
[TBL] [Abstract][Full Text] [Related]
8. Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug users.
Dhalla S; Poole G; Singer J; Patrick DM; Wood E; Kerr T
Vaccine; 2010 Feb; 28(7):1663-7. PubMed ID: 20044049
[TBL] [Abstract][Full Text] [Related]
9. Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda.
Asiki G; Abaasa A; Ruzagira E; Kibengo F; Bahemuka U; Mulondo J; Seeley J; Bekker LG; Delany S; Kaleebu P; Kamali A
Vaccine; 2013 Oct; 31(44):5055-61. PubMed ID: 24021306
[TBL] [Abstract][Full Text] [Related]
10. Participants' characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa.
Hanass-Hancock J; Carpenter B; Reddy T; Nzuza A; Gaffoor Z; Goga A; Andrasik M
Trials; 2021 Dec; 22(1):897. PubMed ID: 34895272
[TBL] [Abstract][Full Text] [Related]
11. Recruitment using respondent driven sampling, risk behaviors assessment and willingness of young female sex workers (18-25 years) in Dar Es Salaam, Tanzania to participate in HIV vaccine trials.
Mbunda T; Tarimo EAM; Bakari M; Sandström E; Kulane A
BMC Public Health; 2019 Nov; 19(1):1537. PubMed ID: 31796002
[TBL] [Abstract][Full Text] [Related]
12. Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study.
Gray GE; Moodie Z; Metch B; Gilbert PB; Bekker LG; Churchyard G; Nchabeleng M; Mlisana K; Laher F; Roux S; Mngadi K; Innes C; Mathebula M; Allen M; McElrath MJ; Robertson M; Kublin J; Corey L;
Lancet Infect Dis; 2014 May; 14(5):388-96. PubMed ID: 24560541
[TBL] [Abstract][Full Text] [Related]
13. Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-positive injection drug users.
Dhalla S; Poole G; Singer J; Patrick DM; Kerr T
Psychol Health Med; 2012; 17(2):223-34. PubMed ID: 22250925
[TBL] [Abstract][Full Text] [Related]
14. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users.
Golub ET; Purvis LA; Sapun M; Safaeian M; Beyrer C; Vlahov D; Strathdee SA
AIDS Behav; 2005 Sep; 9(3):301-9. PubMed ID: 16088366
[TBL] [Abstract][Full Text] [Related]
15. Willingness to participate in future HIV prevention trials in Beira, Mozambique.
Meque I; Dubé K; Bierhuizen L; Zango A; Veldhuijzen N; Cumbe F; Feldblum PJ; van de Wijgert J
Afr J AIDS Res; 2014; 13(4):393-8. PubMed ID: 25555105
[TBL] [Abstract][Full Text] [Related]
16. Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials.
Jaspan HB; Berwick JR; Myer L; Mathews C; Flisher AJ; Wood R; Bekker LG
J Adolesc Health; 2006 Nov; 39(5):642-8. PubMed ID: 17046499
[TBL] [Abstract][Full Text] [Related]
17. The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants.
Volk JE; Hessol NA; Gray GE; Kublin JG; Churchyard GJ; Mlisana K; Nchabeleng M; Buchbinder SP; Bekker LG
Int J STD AIDS; 2014 Apr; 25(5):332-40. PubMed ID: 24104693
[TBL] [Abstract][Full Text] [Related]
18. Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important.
Laher F; Salami T; Hornschuh S; Makhale LM; Khunwane M; Andrasik MP; Gray GE; Van Tieu H; Dietrich JJ
BMC Public Health; 2020 Nov; 20(1):1669. PubMed ID: 33160341
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa.
Malahleha M; Laher F; Dilraj A; Smith P; Gray GE; Grove D; Odhiambo JA; Andrasik MP; Grunenberg NA; Moodie Z; Huang Y; Borate BR; Gillespie KM; Allen M; Atujuna M; Singh N; Kalonji D; Meintjes G; Kotze P; Bekker LG; Janes H
AIDS Behav; 2023 Sep; 27(9):3027-3037. PubMed ID: 36929319
[TBL] [Abstract][Full Text] [Related]
20. Willingness to participate in HIV vaccine trials among a sample of men who have sex with men, with and without a history of commercial sex, Rio de Janeiro, Brazil.
de Souza CT; Lowndes CM; Szwarcwald CL; Sutmöller F; Bastos FI
AIDS Care; 2003 Aug; 15(4):539-48. PubMed ID: 14509868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
